VANCOUVER, British Columbia--()--The Centre for Drug Research and Development (CDRD) and Western Economic Diversification Canada (WD), announced $900,000 in Government of Canada support for the CDRD to establish a leading-edge Biologics Division at its research facilities located on the University of British Columbia campus.
“This investment exemplifies how academia, government and industry are working together to improve the health and quality of life for Canadians and people around the globe, while creating new economic opportunities.”
The integration of biologics into CDRD's existing drug development platform is expected to increase avenues for commercialization of Canadian research in a growing area of new therapeutics and provide additional resources accessible to the local research community and biotechnology sector. The new Biologics division will focus on the discovery and optimization of monoclonal antibodies - the most successful and fastest growing class of biologics, against a significant number of molecular targets in a wide range of diseases. This funding will allow purchase and commission of several pieces of scientific equipment and software, as well as the hiring of highly skilled personnel.
“Our Government is helping support the development of emerging areas of medicine into commercially viable drugs and therapies for all Canadians,” said the Honourable Lynne Yelich, Minister of State for Western Economic Diversification. “This investment exemplifies how academia, government and industry are working together to improve the health and quality of life for Canadians and people around the globe, while creating new economic opportunities.”
“WD continues to be a key catalyst in the start up of important new initiatives in Canada,” said Natalie Dakers, CDRD’s President & CEO. “CDRD is delighted to have WD collaborate with us again on establishing a new Biologics division that further enhances our leading edge drug development platform. Without this kind of support from WD and the Government of Canada, it would not be possible to build such a fully-integrated drug development centre.”
About Western Economic Diversification Canada
Western Economic Diversification Canada (WD) (www.wd-deo.gc.ca) works with the provinces, industry associations and communities to promote the development and diversification of the western economy, coordinates federal economic activities in the West and advances the interests of western Canadians in national decision making.
The Centre for Drug Research and Development (CDRD) (www.cdrd.ca) is a Vancouver-based, independent, not-for-profit public-private organization with a focus on bridging the gap between academic discoveries in the health sciences and the development of new medicines to treat human disease. CDRD provides drug development expertise and infrastructure to enable researchers from leading academic and health research institutions to advance promising, early-stage drug candidates. CDRD combines its drug development platform with a commercial arm, which licenses technologies from affiliated institutions and establishes working collaborations with other biotech companies. The Government of Canada's Networks of Centres of Excellence program has recognized CDRD as a Centre of Excellence in Commercialization in Research (CECR).